Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Staines, Henry M; Kirwan, Daniela E; Clark, David J; Adams, Emily R; Augustin, Yolanda; Byrne, Rachel L; Cocozza, Michael; Cubas-Atienzar, Ana I; Cuevas, Luis E; Cusinato, Martina; Davies, Benedict M O; Davis, Mark; Davis, Paul; Duvoix, Annelyse; Eckersley, Nicholas M; Forton, Daniel; Fraser, Alice J; Garrod, Gala; Hadcocks, Linda; Hu, Qinxue; Johnson, Michael; Kay, Grant A; Klekotko, Kesja; Lewis, Zawditu; Macallan, Derek C; Mensah-Kane, Josephine; Menzies, Stefanie; Monahan, Irene; Moore, Catherine M; Nebe-von-Caron, Gerhard; Owen, Sophie I; Sainter, Chris; Sall, Amadou A; Schouten, James; Williams, Christopher T; Wilkins, John; Woolston, Kevin; Fitchett, Joseph R A; Krishna, Sanjeev; Planche, Tim.

Emerg Infect Dis ; 27(1)2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-33256890

2.

Differential effect of interferon-alpha treatment on AEA and 2-AG levels.

Zajkowska, Zuzanna; Borsini, Alessandra; Nikkheslat, Naghmeh; Russell, Alice; Romano, Graziella F; Tomassi, Simona; Hepgul, Nilay; Forton, Daniel; Agarwal, Kosh; Hotopf, Matthew; Mondelli, Valeria; Zunszain, Patricia; Pariante, Carmine M.

Brain Behav Immun ; 90: 248-258, 2020 11.

Artigo em Inglês | MEDLINE | ID: mdl-32860939

3.

Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.

Foster, Graham R; Agarwal, Kosh; Cramp, Matthew E; Moreea, Sulleman; Barclay, Stephen; Collier, Jane; Brown, Ashley S; Ryder, Stephen D; Ustianowski, Andrew; Forton, Daniel M; Fox, Ray; Gordon, Fiona; Rosenberg, William M; Mutimer, David J; Du, Jiejun; Gilbert, Christopher L; Asante-Appiah, Ernest; Wahl, Janice; Robertson, Michael N; Barr, Eliav; Haber, Barbara.

Hepatology ; 67(6): 2113-2126, 2018 06.

Artigo em Inglês | MEDLINE | ID: mdl-29473975

4.

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.

Zanetto, Alberto; Shalaby, Sarah; Vitale, Alessandro; Mescoli, Claudia; Ferrarese, Alberto; Gambato, Martina; Franceschet, Enrica; Germani, Giacomo; Senzolo, Marco; Romano, Antonietta; Angeli, Paolo; Rugge, Massimo; Farinati, Fabio; Forton, Daniel M; Cillo, Umberto; Burra, Patrizia; Russo, Francesco Paolo.

Liver Transpl ; 23(9): 1103-1112, 2017 09.

Artigo em Inglês | MEDLINE | ID: mdl-28544587

5.

Extrahepatic morbidity and mortality of chronic hepatitis C.

Negro, Francesco; Forton, Daniel; Craxì, Antonio; Sulkowski, Mark S; Feld, Jordan J; Manns, Michael P.

Gastroenterology ; 149(6): 1345-60, 2015 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26319013

6.

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.

Foster, Graham R; Pianko, Stephen; Brown, Ashley; Forton, Daniel; Nahass, Ronald G; George, Jacob; Barnes, Eleanor; Brainard, Diana M; Massetto, Benedetta; Lin, Ming; Han, Bin; McHutchison, John G; Subramanian, G Mani; Cooper, Curtis; Agarwal, Kosh.

Gastroenterology ; 149(6): 1462-70, 2015 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26248087

7.

How much of a problem is resistance in treating hepatitis C?

Forton, Daniel M.

Curr Opin Infect Dis ; 29(6): 625-631, 2016 12.

Artigo em Inglês | MEDLINE | ID: mdl-27673712

8.

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

Baker, Emma H; Patel, Kamal; Ball, Jonathan; Edwards, Sarah; Harrison, Thomas S; Kaul, Arvind; Koh, Mickey; Krishna, Sanjeev; Leaver, Susannah; Kumar, Vinodh; Forton, Daniel M.

Br J Clin Pharmacol ; 87(3): 1584-1586, 2021 03.

Artigo em Inglês | MEDLINE | ID: mdl-32656822

9.

STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection.

Ferenci, Peter; Asselah, Tarik; Foster, Graham R; Zeuzem, Stefan; Sarrazin, Christoph; Moreno, Christophe; Ouzan, Denis; Maevskaya, Marina; Calinas, Filipe; Morano, Luis E; Crespo, Javier; Dufour, Jean-François; Bourlière, Marc; Agarwal, Kosh; Forton, Daniel; Schuchmann, Marcus; Zehnter, Elmar; Nishiguchi, Shuhei; Omata, Masao; Kukolj, George; Datsenko, Yakov; Garcia, Miguel; Scherer, Joseph; Quinson, Anne-Marie; Stern, Jerry O.

J Hepatol ; 62(6): 1246-55, 2015 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-25559324

10.

KIR-HLA interactions extend human CD8+ T cell lifespan in vivo.

Zhang, Yan; Yan, Ada Wc; Boelen, Lies; Hadcocks, Linda; Salam, Arafa; Gispert, Daniel Padrosa; Spanos, Loiza; Bitria, Laura Mora; Nemat-Gorgani, Neda; Traherne, James A; Roberts, Chrissy; Koftori, Danai; Taylor, Graham P; Forton, Daniel; Norman, Paul J; Marsh, Steven Ge; Busch, Robert; Macallan, Derek C; Asquith, Becca.

J Clin Invest ; 133(12)2023 06 15.

Artigo em Inglês | MEDLINE | ID: mdl-37071474

11.

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

Schaefer, Martin; Capuron, Lucile; Friebe, Astrid; Diez-Quevedo, Crisanto; Robaeys, Geert; Neri, Sergio; Foster, Graham R; Kautz, Achim; Forton, Daniel; Pariante, Carmine M.

J Hepatol ; 57(6): 1379-90, 2012 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-22878466

12.

Hepatitis C - the brain strain.

Forton, Daniel M.

Liver Int ; 36(10): 1415-7, 2016 10.

Artigo em Inglês | MEDLINE | ID: mdl-27616335

13.

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

Cooke, Graham S; Pett, Sarah; McCabe, Leanne; Jones, Chris; Gilson, Richard; Verma, Sumita; Ryder, Stephen D; Collier, Jane D; Barclay, Stephen T; Ala, Aftab; Bhagani, Sanjay; Nelson, Mark; Ch'Ng, Chinlye; Stone, Ben; Wiselka, Martin; Forton, Daniel; McPherson, Stuart; Halford, Rachel; Nguyen, Dung; Smith, David; Ansari, Azim; Dennis, Emily; Hudson, Fleur; Barnes, Eleanor J; Walker, Ann Sarah.

Wellcome Open Res ; 6: 93, 2021.

Artigo em Inglês | MEDLINE | ID: mdl-34405118

14.

A study of muscle tissue oxygenation and peripheral microcirculatory dysfunction in cirrhosis using near infrared spectroscopy.

Thomson, Sam J; Cowan, Matthew L; Forton, Daniel M; Clark, Sarah J; Musa, Saif; Grounds, Michael; Rahman, Tony M.

Liver Int ; 30(3): 463-71, 2010 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-19912533

15.

English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed.

Drysdale, Kathryn; Ntuli, Yevedzo; Bestwick, Jonathan; Gelson, William; Agarwal, Kosh; Forton, Daniel; Mutimer, David; Elsharkawy, Ahmed M; Townley, Ceri; Mahomed, Faizel; Foster, Graham R.

Aliment Pharmacol Ther ; 52(1): 168-181, 2020 07.

Artigo em Inglês | MEDLINE | ID: mdl-32441382

16.

Cognitive improvement after HCV eradication: Extending the benefits.

Bajaj, Jasmohan S; Forton, Daniel M.

Hepatology ; 58(2): 480-2, 2013 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-23696270

17.

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.

Russell, Alice; Hepgul, Nilay; Nikkheslat, Naghmeh; Borsini, Alessandra; Zajkowska, Zuzanna; Moll, Natalie; Forton, Daniel; Agarwal, Kosh; Chalder, Trudie; Mondelli, Valeria; Hotopf, Matthew; Cleare, Anthony; Murphy, Gabrielle; Foster, Graham; Wong, Terry; Schütze, Gregor A; Schwarz, Markus J; Harrison, Neil; Zunszain, Patricia A; Pariante, Carmine M.

Psychoneuroendocrinology ; 100: 276-285, 2019 02.

Artigo em Inglês | MEDLINE | ID: mdl-30567628

18.

Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations.

Forton, Daniel; Weissenborn, Karin; Bondin, Mark; Cacoub, Patrice.

Antivir Ther ; 23(Suppl 2): 47-55, 2018.

Artigo em Inglês | MEDLINE | ID: mdl-30451150

19.

Depression and anxiety in patients receiving interferon-alpha: The role of illness perceptions.

Hepgul, Nilay; Pariante, Carmine M; Baraldi, Sara; Borsini, Alessandra; Bufalino, Chiara; Russell, Alice; Agarwal, Kosh; Cleare, Anthony J; Forton, Daniel M; Henderson, Max; Mondelli, Valeria; Ranjith, Gopinath; Hotopf, Matthew.

J Health Psychol ; 23(11): 1405-1414, 2018 09.

Artigo em Inglês | MEDLINE | ID: mdl-27458106

20.

Hepatitis C treatment--clearing the mind.

Forton, Daniel M.

J Hepatol ; 56(3): 513-4, 2012 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-22115889

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Differential effect of interferon-alpha treatment on AEA and 2-AG levels.

Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trial.

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.

Extrahepatic morbidity and mortality of chronic hepatitis C.

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.

How much of a problem is resistance in treating hepatitis C?

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection.

KIR-HLA interactions extend human CD8+ T cell lifespan in vivo.

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

Hepatitis C - the brain strain.

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

A study of muscle tissue oxygenation and peripheral microcirculatory dysfunction in cirrhosis using near infrared spectroscopy.

English hepatitis C registry data show high response rates to directly acting anti-virals, even if treatment is not completed.

Cognitive improvement after HCV eradication: Extending the benefits.

Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.

Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations.

Depression and anxiety in patients receiving interferon-alpha: The role of illness perceptions.

Hepatitis C treatment--clearing the mind.